Medicare AdvantageCoverageMedium impact
MA07.015a, Evaluation and Management (E&M) of Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS)
Independence Blue Cross·Family Medicine, Internal Medicine, Endocrinology +2 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.015a regarding Evaluation and Management of Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS) has been reissued. This policy update affects E&M services for diabetic neuropathy patients and may impact billing requirements or coverage criteria for these specific encounters.
Action Required
Before October 1, 2025: Billing team should review the complete MA07.015a policy at the IBX website to understand any changes to E&M billing requirements for diabetic peripheral neuropathy with LOPS. Update billing protocols and provider documentation requirements as specified in the full policy. Ensure staff are trained on any new coverage criteria or documentation standards.